rs17248882

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. BS1PP1_ModerateBS3_Supporting

This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1706-10G>A variant is classified as Likely benign for Familial Hypercholesterolemia by applying evidence codes BS1, BS3_supporting and PP1_moderate as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012). The supporting evidence is as follows:BS1 - FAF = 0.002911 (0.2911%) in Latino/Admixed American exomes (gnomAD v2.1.1), so BS1 is Met.BS3_supporting - 2 Level 3 assays: PMID:25741862: Heterozygous patients' lymphocytes, RNA assays - result - Normal LDLR transcripts identified by sequencing.PMID:19208450: Heterozygous patients' Epstein Barr virus transformed lymphocytes, RNA assays - result - Normal LDLR transcripts, 43% of mutant transcripts (from total transcripts) in htz cells.---- Aberrant transcripts are not detected, so BS3_Supporting is Met.PP1_moderate - Variant segregates with FH phenotype in at least 5 informative meiosis from 2 families from Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge: 5 affected family members have the variant, so PP1_Moderate is Met.Variant has 1 Strong plus 1 Supporting evidence codes towards Benign, enough to classify as Likely benign and only 1 Moderate evidence code towards Pathogenic, not enough for Likely pathogenic, so we are confident in classifying this variant as Likely benign. LINK:https://erepo.genome.network/evrepo/ui/classification/CA035940/MONDO:0007750/013

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0020 ( 8 hom. )

Consequence

LDLR
NM_000527.5 intron

Scores

2
Splicing: ADA: 0.001607
2

Clinical Significance

Likely benign reviewed by expert panel U:3B:27

Conservation

PhyloP100: -0.240

Publications

11 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

PP1
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.
BS3
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
NM_000527.5
MANE Select
c.1706-10G>A
intron
N/ANP_000518.1P01130-1
LDLR
NM_001195798.2
c.1706-10G>A
intron
N/ANP_001182727.1P01130-5
LDLR
NM_001195799.2
c.1583-10G>A
intron
N/ANP_001182728.1P01130-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LDLR
ENST00000558518.6
TSL:1 MANE Select
c.1706-10G>A
intron
N/AENSP00000454071.1P01130-1
LDLR
ENST00000252444.10
TSL:1
c.1964-10G>A
intron
N/AENSP00000252444.6J3KMZ9
LDLR
ENST00000558013.5
TSL:1
c.1706-10G>A
intron
N/AENSP00000453346.1P01130-5

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
244
AN:
152182
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00302
Gnomad ASJ
AF:
0.00230
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00225
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00232
AC:
584
AN:
251472
AF XY:
0.00247
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00341
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00274
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00199
AC:
2901
AN:
1461206
Hom.:
8
Cov.:
34
AF XY:
0.00204
AC XY:
1481
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33468
American (AMR)
AF:
0.00344
AC:
154
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00402
AC:
105
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00276
AC:
238
AN:
86210
European-Finnish (FIN)
AF:
0.000618
AC:
33
AN:
53394
Middle Eastern (MID)
AF:
0.0127
AC:
67
AN:
5294
European-Non Finnish (NFE)
AF:
0.00192
AC:
2131
AN:
1111952
Other (OTH)
AF:
0.00265
AC:
160
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
163
327
490
654
817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152300
Hom.:
1
Cov.:
33
AF XY:
0.00154
AC XY:
115
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41562
American (AMR)
AF:
0.00301
AC:
46
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00230
AC:
8
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00225
AC:
153
AN:
68036
Other (OTH)
AF:
0.00473
AC:
10
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00190
Hom.:
0
Bravo
AF:
0.00185
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
13
Hypercholesterolemia, familial, 1 (16)
-
-
5
not provided (5)
-
-
4
Familial hypercholesterolemia (4)
-
-
4
not specified (4)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.2
DANN
Benign
0.74
PhyloP100
-0.24
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0016
dbscSNV1_RF
Benign
0.41
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17248882; hg19: chr19-11227525; API